Clinical pathological significance of iron metabolism with chronic hepatitis C patients

Hepatology Research

Volumn 24, Issue 3, 2002, Pages 245-255

  Chino, Sanae ^a   Moriyama, Mitsuhiko ^a   Matsumura, Hiroshi ^a   Ono, Yoshiki ^a   Arakawa, Yasuyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; HCV RNA; Iron; Liver histology; Serum ferritin levels; Sexual differences

Indexed keywords

AMINOTRANSFERASE; FERRITIN; IRON;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HUMAN; IRON METABOLISM; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER SINUSOID; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PORTAL VEIN; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE;

EID: 0036845135     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00110-9     Document Type: Article

References (20)

1. Boucher E, Bourienne A, Adams P, Turlin B, Brissot P, Deugnier Y. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 1997;41:115-20.
2. Piperno A, D'Alba R, Fargion S, et al. Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 1995;7:1203-8.
3. Arber N, Konokoff FM, Moshkowitz M, et al. Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig Dis Sci 1994;39:2656-9.
4. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999;116:127-34.
5. Britton RS, Tavill AS, Bacon BR. Mechanisms of iron toxicity. In: Brock JH, Halliday JW, Pippard MJ, editors. Iron metabolism in health and disease. Philadelphia: WB Saunders, 1994:311-51.
6. Chapoutot C, Esslimani M, Joomaye Z, et al. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 2000;46:711-4.
7. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-13.
8. Ikura Y, Morimoto H, Johmura H, Fukui M, Sakurai M. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol 1996;91:1367-73.
9. Izumi N, Enomoto N, Uchihara M, et al. Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Dig Dis Sci 1996;41:989-94.
10. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
11. Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981;80:557-65.
12. Jacobs A, Worwood M. Ferritin in serum. Clinical and biochemical implications. N Engl J Med 1975;292:951-6.
13. Barbaro G, Di Lorenzo G, Ribersani M, et al. Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol 1999;30:774-82.
14. Gossard AA, Gross JB, Jr., Burgant LJ, Poterucha JJ, Zein NN. Significance of iron indices in hepatitis C, alcoholic liver disease. (Abstract) Gastroenterology 1995;108:A1075.
15. Nathan L, Chaudhuri G. Antioxidant and prooxidant actions of estrogens: potential physiological and clinical implications. Semin Reprod Endocrinol 1998;16:309-14.
16. Leal AM, Ruiz-Larrea MB, Martinez R, Lacort M. Cytoprotective actions of estrogens against tert-butyl hydroperoxide-induced toxicity in hepatocytes. Biochem Pharmacol 1998;56:1463-9.
17. Feder JN, Gnirke A, Thomas W, et al. Anovel MHC class-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
18. Shiono Y, Ikeda R, Hayashi H, et al. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Intern Med 2001;40:852-6.
19. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994;89:986-8.
20. Piperno A, Sampietro M, D'Alba R, et al. Iron stores, response to alpha-interferon therapy and effects of iron depletion in chronic hepatitis C. Liver 1996;16:248-54.